These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10582786)

  • 1. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements.
    Homburg R; Howles CM
    Hum Reprod Update; 1999; 5(5):493-9. PubMed ID: 10582786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome.
    Homburg R; Levy T; Ben-Rafael Z
    Fertil Steril; 1995 Apr; 63(4):729-33. PubMed ID: 7890055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon).
    Buckler HM; Robertson WR; Anderson A; Vickers M; Lambert A
    Hum Reprod; 1999 Dec; 14(12):2969-73. PubMed ID: 10601080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.
    Hughes E; Collins J; Vandekerckhove P
    Cochrane Database Syst Rev; 2000; 1996(2):CD000087. PubMed ID: 10796690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group.
    Coelingh Bennink HJ; Fauser BC; Out HJ
    Fertil Steril; 1998 Jan; 69(1):19-25. PubMed ID: 9457926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens.
    Balasch J; Fábregues F; Creus M; Puerto B; Peñarrubia J; Vanrell JA
    Hum Reprod; 2001 Apr; 16(4):652-6. PubMed ID: 11278212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Bayram N; van Wely M; van Der Veen F
    Cochrane Database Syst Rev; 2001; (2):CD002121. PubMed ID: 11406034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance].
    Chen W; Zhang Y; Dai Q
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):588-90. PubMed ID: 11372406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome.
    Hamilton-Fairley D; Kiddy D; Watson H; Sagle M; Franks S
    Hum Reprod; 1991 Sep; 6(8):1095-9. PubMed ID: 1806568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
    Fauser BC; Donderwinkel P; Schoot DC
    Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):309-30. PubMed ID: 8358893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of baseline ovarian volume to ovarian response in World Health Organization II anovulatory patients who underwent ovulation induction with gonadotropins.
    Lass A; Vassiliev A; Decosterd G; Warne D; Loumaye E
    Fertil Steril; 2002 Aug; 78(2):265-9. PubMed ID: 12137861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose ovulation induction with urinary gonadotropins or recombinant follicle stimulating hormone in patients with polycystic ovary syndrome.
    Szilágyi A; Bártfai G; Mánfai A; Koloszár S; Pál A; Szabó I
    Gynecol Endocrinol; 2004 Jan; 18(1):17-22. PubMed ID: 15106360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of low dose purified FSH in ovulation induction following pituitary desensitization in polycystic ovarian syndrome.
    Buckler HM; Critchley HO; Cantrill JA; Shalet SM; Anderson DC; Robertson WR
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):209-17. PubMed ID: 8435902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
    Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
    Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment.
    Fulghesu AM; Apa R; Belosi C; Ciampelli M; Selvaggi L; Cucinelli F; Caruso A; Mancuso S; Lanzone A
    Horm Res; 2001; 55(5):224-8. PubMed ID: 11740143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment options of clomiphene-resistant polycystic ovary syndrome related infertility].
    Liang X; Zhuang G; Zhou C
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):591-3. PubMed ID: 11372407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
    Burgués S;
    Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of persistent anovulation in polycystic ovarian disease by administration of chronic low-dose follicle-stimulating hormone.
    Kamrava MM; Seibel MM; Berger MJ; Thompson I; Taymor ML
    Fertil Steril; 1982 Apr; 37(4):520-3. PubMed ID: 6802679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.